Formoterol Fumarate Solution
Product Images NDC 43598-778

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate (NDC 43598-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel (Cartonlabel)

Cartonlabel (Cartonlabel)
Packaging label for Formoterol Fumarate Inhalation Solution 20 mcg/2 mL vial by Dr. Reddy's Laboratories Inc., NDC 43598-778-30. The label indicates sterile unit dose vials, individually wrapped, for oral inhalation only, with 30 vials per carton. Active ingredient is formoterol fumarate dihydrate, USP, and includes inactive ingredients. Storage and usage instructions are detailed.*
FDA Label Image

Formoterol Fumarate Figure 1 (Figure1)

Formoterol Fumarate Figure 1 (Figure1)
A line chart comparing mean FEV1 (in liters) over 12 hours for Formoterol fumarate 20 mcg versus placebo. The chart shows FEV1 values on the vertical axis and time in hours on the horizontal axis, depicting changes in respiratory function with treatment and placebo.*
FDA Label Image

Formoterol Fumarate Figure 2 (Figure2)

Formoterol Fumarate Figure 2 (Figure2)
A line graph depicting mean FEV1 in liters over 12 hours comparing Formoterol fumarate 20 mcg (N=123) and placebo (N=114). The chart shows higher FEV1 values for Formoterol fumarate across the time points measured, with FEV1 on the vertical axis and hours on the horizontal axis.*
FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
An instructional illustration showing how to prepare a respiratory inhalation device. It depicts a hand inserting a cartridge or dose container into the inhaler base, likely demonstrating the initial step in device assembly or medication loading for Formoterol Fumarate inhalation solution.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
An instructional black and white line drawing showing a hand holding a respiratory inhalation device with a mouthpiece and a portion of the delivery mechanism separated, likely demonstrating assembly or usage steps related to Formoterol Fumarate inhalation solution.*
FDA Label Image

Figures 3 And 4 (Image 03)

Figures 3 And 4 (Image 03)
An instructional illustration showing a person using a formoterol fumarate inhaler. The first image depicts the user placing the inhaler mouthpiece between the lips for inhalation. The second image shows the user with a mask attached to the inhaler, covering the nose and mouth during administration.*
FDA Label Image

Structural Formula (Structural Formula)

Structural Formula (Structural Formula)
Chemical structure of formoterol fumarate dihydrate, showing the molecular arrangement of formoterol linked with fumaric acid and associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.